Compare Align Technology, Inc. (ALGN) vs ProShares Ultra Gold ETF (UGL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs ProShares Ultra Gold ETF — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while ProShares Ultra Gold ETF trades at $44.87. The key difference: Align Technology, Inc. is trading nearer its 52-week high, ProShares Ultra Gold ETF nearer its low. Which is the better fit depends on your goals.
| ALGN | UGL | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $207.19 | $85.62 |
52-Week Low | $124.88 | $33.59 |
Enterprise Value | $11.92B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
UGL, the ProShares Ultra Gold ETF, trades at $45.76, down 0.74% on the day, reflecting ongoing pressure in the gold market. Technical indicators show a bearish trend with moving averages signaling sell pressure, while oscillators remain neutral. Recent news highlights gold's 25% decline from record highs amid Fed policy uncertainty and geopolitical tensions, though central bank buying provides some support. The ETF's leveraged structure amplifies daily gold price movements, impacting short-term performance.
The outlook for UGL hinges on gold price direction, with near-term risks from rising Treasury yields and inflation data. Opportunities exist if geopolitical tensions or dovish Fed shifts boost gold, but volatility remains high. Investors should note the ETF's decay risk from daily rebalancing in stagnant or volatile markets, making it more suitable for tactical plays than long-term holds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About ProShares Ultra Gold ETF
UGL is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Bloomberg Gold Subindex. It is a tactical tool designed for sophisticated investors to magnify short-term bullish views on gold prices through the use of futures and swap contracts, rather than holding physical bullion.
Read more on UGL →
